Semler Scientific - SMLR Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Semler Scientific in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SMLR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SMLR, but not buy additional shares or sell existing shares.
View SMLR analyst ratings or view top-rated stocks.

1 brokers have issued 1 year target prices for Semler Scientific's stock. Their SMLR share price forecasts range from $45.00 to $45.00. On average, they predict the company's stock price to reach $45.00 in the next twelve months. This suggests a possible upside of 74.9% from the stock's current price.
View analysts price targets for SMLR or view top-rated stocks among Wall Street analysts.

Semler Scientific's stock was trading at $33.00 at the beginning of the year. Since then, SMLR stock has decreased by 22.0% and is now trading at $25.73.
View the best growth stocks for 2023 here.

Semler Scientific, Inc. (OTCMKTS:SMLR) announced its quarterly earnings data on Sunday, October, 31st. The medical equipment provider reported $0.51 earnings per share for the quarter, missing the consensus estimate of $0.65 by $0.14. The medical equipment provider had revenue of $13.99 million for the quarter, compared to the consensus estimate of $15.60 million. Semler Scientific had a trailing twelve-month return on equity of 28.20% and a net margin of 25.27%.

ETFs with the largest weight of Semler Scientific (OTCMKTS:SMLR) stock in their portfolio include Janus Henderson Small Cap Growth Alpha ETF (JSML) and Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD) and

Semler Scientific issued an update on its first quarter 2023 earnings guidance on Wednesday, March, 22nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $17.40 million-$17.80 million, compared to the consensus revenue estimate of $15.30 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other Semler Scientific investors own include BioSpecifics Technologies (BSTC), Anavex Life Sciences (AVXL), Cornerstone OnDemand (CSOD), Innoviva (INVA), Novo Nordisk A/S (NVO), Sorrento Therapeutics (SRNE), Vertex Pharmaceuticals (VRTX), Acer Therapeutics (ACER), Allena Pharmaceuticals (ALNA) and Digital Turbine (APPS).

Semler Scientific trades on the OTCMKTS under the ticker symbol "SMLR."

Semler Scientific's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Cerity Partners LLC (10.25%), AltraVue Capital LLC (6.39%), Avalon Investment & Advisory (1.88%), Rice Hall James & Associates LLC (1.79%), Franklin Resources Inc. (1.18%) and New York State Common Retirement Fund (1.06%). Insiders that own company stock include Douglas Murphy-Chutorian, HC Chang & Diana Sho William and Wayne T Pan.
View institutional ownership trends.

Shares of SMLR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SMLR stock can currently be purchased for approximately $25.73.

Semler Scientific (OTCMKTS:SMLR) has a market capitalization of $175.99 million and generates $56.69 million in revenue each year. The medical equipment provider earns $17.22 million in net income (profit) each year or $1.79 on an earnings per share basis.

The company employs 124 workers across the globe.

Semler Scientific's mailing address is 911 BERN COURT SUITE 110, SAN JOSE CA, 95112. The official website for the company is www.semlerscientific.com. The medical equipment provider can be reached via phone at (877) 774-4211 or via email at susan@sanoonan.com.